CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar bigchuck28 (68.95) Submitted: 11/18/2008 11:45:34 PM : Outperform Start Price: $9.66 CRY Score: -110.03

Strong fundamentals.

Featured Broker Partners


Advertisement